Table 1 List of Potentially Inappropriate Medications Used in the Present Study*

Indomethacin

Cimetidine

Phenylbutazone

Stimulant laxatives

Concomitant use of 2 or more NSAIDs

Long-acting sulfonylureas

Anticholinergic antidepressants

Methocarbamol, baclofen, tetrazepam

Antipsychotic drugs

Cerebral vasodilators (dihydroergocristine, ginkgo-biloba, pentoxifylline, ...)

Anticholinergic hypnotic drugs

Meprobamate

Anticholinergic antihistamines

Gastrointestinal antispasmodic drugs with anticholinergic properties

Anticholinergic muscle relaxants and antispasmodic drugs

Antiemetics, cough suppressants, nasal decongestants, or antidrowsiness drugs with anticholinergic properties

Concomitant use of drugs with anticholinergic properties

Dipyridamole

Long-acting benzodiazepines (half-life ≥ 20 h)

Nitrofurantoin

Centrally acting antihypertensives

Concomitant use of 2 or more psychotropic drugs from the same therapeutic class

Short-acting calcium-channel blockers

Concomitant use of anticholinesterase drugs and drugs with anticholinergic properties

Reserpine

Barbiturates (except phenobarbital)

Disopyramide

Doxazosin

Ticlopidine